Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Lung Cancer

Jane McDonald steps back from limelight after losing fiancé

Eddie Rothe died after a battle with lung cancer in April last year

Liverpool Echo

Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know

After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.

Benzinga

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

Amgen (NASDAQ:AMGN) announced top-line results from the global Phase 3 CodeBreaK 200 trial evaluating once daily oral LUMAKRAS (sotorasib) in patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC), the study met primary endpoint. Amgen shares traded in a range of $238.29 to $240.31 on day volume of 2.43 million shares, closed regular…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Scots newlywed diagnosed with cancer weeks after dream wedding in Greece

Stuart Roseburgh, from Corstorphine, said his wife's diagnosis was a further blow for the family after his mother, Carol, 63, was told she has lung cancer in February last year.

Daily Record

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Merck's (NYSE:MRK) lead asset MK-2060 for the reduction in risk of major thrombotic cardiovascular events in patients with end-stage renal disease (ESRD). Merck shares traded in a range of $89.72 to $90.97 on day volume of 5.2…

Benzinga

Woman who thought she just had a 'bad cough' diagnosed with life-threatening disease

Karen McCarthy went to see her GP after suffering from a bad chest infection for two weeks

Irish Mirror

Kathy Griffin asks fans to help her understand cancer scan after surgeon ‘ghosts her’

The comedian was diagnosed with lung cancer last year

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Woman survived lung cancer after visiting GP with bad cough

X-rays revealed that Karen McCarthy had England's deadliest cancer - and now she is urging people to get checked out

Wales Online

Lung cancer symptoms as woman thought deadly condition was bad cough

Cancer health chiefs are urging people to go to their GP if they are experiencing symptoms.

Daily Record

Woman who thought she had bad cough diagnosed with 'UK's deadliest cancer'

Karen McCarthy had been suffering with a chest infection for two weeks when she made an appointment to see her GP.

Daily Record

Woman thought she had a bad cough - only to receive a life-threatening diagnosis

Karen McCarthy, from Manchester, "feels lucky to be alive" after being diagnosed with lung cancer and getting part of her right lung removed to deal with the tumour

Daily Mirror

'I thought I just had a bad cough, then got a life-threatening diagnosis'

Karen is warning others of the symptoms you should look out for

Manchester Evening News

Colorado medical schools use live actors to teach future doctors, but the pandemic permanently changed some of the ways they do it

DENVER -- Christina Cass has spent the last 25 years of her career in and out of hospital gowns. She’s been poked and prodded, diagnosed with dozens of different ailments from lung cancer to Alzheimer’s disease, and treated for her knee and for injuries after a car accident.

The Denver Post

Research: Cancer-related fibroblasts induce drug sensitivity

They discovered that the presence of cancer-associated fibroblasts had varying effects on tumour cells based on both the type of non-small cell lung cancer and the drug used for treatment. Full story on Dynamite News:

Dynamite News

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy candidate for solid tumor cancers, were published today in Nature Medicine. The initial results from the study are expected during second half of 2023. Gritstone shares traded in a range of $3.96 to $4.24…

Benzinga

Recap Of Friday's Biotech Catalysts - End Of the Day Summary

Pfizer (NYSE:PFE) announced positive top-line results from its pivotal U.S. Phase 3 study in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for the prevention of invasive pneumococcal disease (IPD). The study met two co-primary objectives, associated with immunogenicity responses. Pfizer shares traded in a range of $48.55 to…

Daily Mirror

Mum thought her symptoms were long Covid before getting devastating cancer diagnosis

After catching Covid this year Vickie Cooney, 42, thought the symptoms she was experiencing were side effects, however a scan shockingly revealed she has lung cancer - which is spreading

Zenger

New Combination Immuno-Therapy Shows Promise For Lung Cancers

Deadly cancers may have met their match in an innovative immunotherapy in combination with a drug that blocks a genetic mutation in lung cancer, according to a new study.

Get all your
news in one place.

100's of premium titles.
One news app.

Daily Mirror

Woman, 29, given cough syrup for a 'simple bug' which turns out to be terminal cancer

Alix Burnard remains optimistic in spite of her incurable diagnosis, but has advised others to never ignore a cough after brushing off her symptoms last year

Daily Mirror

Wildlife SOS' Simon Cowell reveals terminal cancer diagnosis and vows to continue legacy

The presenter of Wildlife SOS Simon Cowell has sadly been diagnosed with lung cancer as his Foundation vows to continue his legacy and commitment to animal rescue

Benzinga

Recap of Monday's Biotech Catalysts - End Of the Day Summary

Kodiak Sciences Inc. (NASDAQ:KOD) announced positive topline results its BEACON Phase 3 study of tarcocimab tedromer (KSI-301; tarcocimab) in patients with macular edema due to retinal vein occlusion. Kodiak shares traded in a range of $10.02 to $11.79 on a day volume of 4.05 million shares, closed regular trading session…

Tribune News Service

Do wildfires put Californians at higher risk for lung cancer?

In California and across the country, more people are likely to die from lung cancer than any other cancer, the American Lung Association states in an August press release, as wildfire season is in full swing.

The Independent UK

NHS warns people not to ignore common lung cancer symptoms

‘It probably won’t be cancer but catching it early can help save lives,’ says national clinical director for cancer

Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ:MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns. MediWound shares traded in a range of $1.6 to $1.76 on a day…

The Independent UK

NHS warns people not to ignore common lung cancer symptoms

‘It probably won’t be cancer but catching it early can help save lives,’ says national clinical director for cancer

1 … 24 25 26 27

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.